We have previously shown that administration of antiprogestin (AP) type II RU486 to ovariectomized (OVX) rats on the morning of pro-oestrus decreases the magnitude of the preovulatory gonadotrophin surge. This suggests that the effect of RU486 on LHRH-dependent gonadotrophin release may be independent of its ability to block progesterone actions. The aim of the present research was to study the possible site of RU486 action and to determine whether the gonadotrophin-suppressive effect of APs RU486 and ZK299 is dependent on the oestrogen background.
Introduction
In the cyclic rat, progesterone inhibits or stimulates gonadotrophin secretion depending on the time of the oestrous cycle. From oestrus throughout dioestrus, progesterone potentiates the negative feedback effects of oestradiol; during pro-oestrus, progesterone facilitates the preovulatory release of gonadotrophins (Rao & Mahesh 1986 , Mahesh & Muldoon 1987 , Brann & Mahesh 1991 , Brann et al. 1991 , allows the expression of the folliclestimulating hormone (FSH) secondary surge during early oestrus (Knox et al. 1993 , Tébar et al. 1995a , and extinguishes, 24 h later, the neural signal controlling gonadotrophin surge (Freeman et al. 1976 , Lustig et al. 1988 .
In 1989, Ortmann et al., using primary cultures of pituitary cells from female rats, reported that the antiprogestin (AP), RU486, an antiprogestagen at the receptor with antiglucocorticoid activity (Baulieu 1989) , abolished the facilitatory and inhibitory actions of progesterone on luteinizing hormone-releasing hormone (LHRH)-induced luteinizing hormone (LH) secretion. They also reported that RU486 itself reduced the LH response to LHRH and that this inhibitory effect is enhanced in the presence of oestrogen, attributing such direct inhibitory action of RU486 to a non-specific toxic or pharmacological effect of the compound (Ortmann et al. 1989) .
Pro-oestrous administration of RU486 to cyclic rats reduces serum concentrations of FSH and LH on the pro-oestrous afternoon in both intact (Rao & Mahesh 1986 ) and ovariectomized (OVX) rats (Tébar et al. 1996) , whereas OVX itself on the morning of pro-oestrus has no effect (Tébar et al. 1996) . These and other findings have given rise to the hypothesis that activation of oestrogen-dependent progesterone receptor (PR) through a ligand-independent mechanism may be involved in the regulation of reproductive processes (Waring & Turgeon 1992 , Turgeon & Waring 1994 , Szabo et al. 1996 , Levine 1997 , Cenni & Picard 1999 , Sánchez-Criado et al. 1999 . The physiological relevance of these findings is not yet known.
The aim of the present study was to determine, in vivo and in vitro, whether APs RU486 (type II) and ZK299 (type I), which differ in the mechanism of action (KleinHitpass et al. 1991 , Beck et al. 1996 , affect, directly at the pituitary, LHRH-dependent LH and FSH secretion in female rats. Results showed that in pro-oestrus, but not in metoestrus, APs reduced basal and LHRH-stimulated LH and FSH secretion at the pituitary level regardless of the natural ligand.
Materials and Methods

Animals
Adult cyclic female Wistar rats weighing 185-210 g were used. The rats were housed under a 14 h light:10 h darkness schedule, with lights on at 0500 h and at 21-23 C room temperature. Vaginal smears were taken daily and only rats showing consistent 4-day cycles were used in these experiments.
Drug treatments and surgery
APs RU486 (11 -[4-dimethyl-aminophenyl]-17 -hydroxy-17 -[prop-1-inyl]-estra-4,9-diene-3-one) (Exelgyn, Paris, France) (Philibert et al. 1985) and hydroxy propyl]-13a-methyl-4,9 gonadien-3-one) (Schering, Berlin, Germany) (Neef et al. 1984) were suspended in olive oil at a concentration of 20 mg/ml. Rats were injected s.c. at 0900 h on pro-oestrus with 0·2 ml of these suspensions. Controls were given 0·2 ml oil.
OVX or control sham-OVX was performed under light ether anaesthesia at 0900 h on pro-oestrus.
In order to block endogenous LHRH release, rats were given an i.p. injection of 60 mg/kg sodium pentobarbitone (PB) (Sanofi Sante, Libourne Cedex, France) at 1300 h on pro-oestrus.
Synthetic LHRH (Peninsula 7201; Peninsula Laboratory, Inc., Merseyside, UK) was dissolved in saline at a concentration of 200 ng/ml, and 0·5 ml of this solution was injected i.p. at 1600 h on pro-oestrus. Control injections consisted of 0·5 ml saline.
Collection of serum and tissues
Rats were killed by decapitation at 1830 h on pro-oestrus. Trunk blood was collected, allowed to clot, and centrifuged at 24 C for 10 min. Serum was stored frozen at 20 C until assayed for LH and FSH. The median eminence (ME) was dissected under a stereomicroscope using fine iris scissors and homogenized (ultrasound) in 100 µl 0·1 M acetic acid. After centrifugation, supernatants were stored frozen at 20 C until assayed for LHRH.
Experiments
The first experiment studied the effects of RU486 and ZK299 on serum LH and FSH concentrations and on ME LHRH content at 1830 h on pro-oestrus in OVX or sham-OVX rats. In the second experiment we evaluated the pituitary responsiveness in vivo to LHRH in rats injected with APs. For this purpose, OVX and sham-OVX rats were injected with PB on pro-oestrus to prevent endogenous release of LHRH and administered with LHRH. Finally, in the third experiment, pituitaries from pro-oestrous or metoestrous rats were rapidly removed at 1000 h. The posterior lobe was dissected and discarded. The anterior pituitaries were cut in half and the halves divided into four parts. Fragments from each hemipituitary were incubated in medium only or in medium containing 1, 10 or 100 nM LHRH in the presence or absence of 20 nM RU486 or ZK299.
Incubation of pituitaries
Pituitaries were incubated in glass scintillation vials in a Dubnoff shaker at 37 C with constant shaking (60 cycles/ min) in an atmosphere of 95% CO 2 -5% O 2 . Each vial contained 1 ml Dulbecco's modified Eagle's medium with 4·5 g/l glucose without -glutamine or phenol red containing BSA (0·1%, w/v). The pH was 7·4. At the end of preincubation (60 min), pituitaries were incubated for 120 min with medium only, or with medium containing 20 nM RU486 or ZK299; thereafter, the incubation medium was removed, immediately frozen until assayed for FSH and LH and replaced by fresh medium containing, in addition to RU486 or ZK299, 1, 10 or 100 nM LHRH. At the end of the second incubation period (120 min), the medium was immediately frozen until assayed for LH and FSH.
RIAs
Serum LH and FSH concentrations were measured in duplicate 25 µl aliquots using double-antibody RIA methods with RIA kits supplied by NIH (Bethesda, MD, USA) and a previously described microassay method (Sáchez-Criado et al. 1990) . Rat LH-I-9 and FSH-I-8 were labelled with 125 I by the chloramine T method (Greenwood et al. 1963) . In order to obviate interassay variability, all samples were analysed in the same assay. Intra-assay coefficients of variation were 7 and 8% for LH and FSH respectively. Assay sensitivities were 7·5 and 50 pg/tube for LH and FSH respectively. Serum LH and FSH concentrations were expressed as ng/ml of serum of the reference preparation LH-rat-RP-3 and FSH-rat-RP-2 respectively. LHRH content from ME was measured in duplicate using previously characterized LHRH antibody HU-60 provided by Dr H F Urbanski (Neuroscience Division, Oregon Regional Primate Research Center, Beaverton, OR, USA), and synthetic LHRH (Peninsula 7201) as the reference standard and for labelling with 125 I. Details of this assay have previously been published (Sánchez-Criado et al. 1993 . In order to avoid any interassay variability, all samples were run in the same assay. Intraassay variability was 9%, and the assay sensitivity was 0·25 pg/tube. LHRH content was expressed as ng/ME.
Statistical analysis
Results are expressed as means ... Data were analysed by two-way ANOVA using the Newman-Keuls multiple range test when two means had to be compared. Results were considered significant at P<0·05.
Results
Effect of AP treatment on ME LHRH content, serum FSH and LH concentration on the pro-oestrous afternoon in intact and OVX rats
OVX had no significant effect on either ME LHRH content or serum LH concentrations on the pro-oestrous afternoon but doubled FSH levels as expected (Fig. 1 ). Administration of RU486 or ZK299 significantly reduced serum LH and FSH concentrations in both intact and OVX rats without affecting ME LHRH content (Fig. 1) .
Effectiveness of PB and LHRH in blocking and stimulating FSH and LH release respectively
Administration of PB increased significantly (P<0·05) ME LHRH content (Figs 1 and 2) and suppressed serum FSH (2·9 2·0 ng/ml) and LH (1·9 0·8 ng/ml) concentrations with respect to the control values (10·9 1·6 and 11·1 2·6 ng/ml respectively) on the pro-oestrous afternoon. LHRH injection to PB-blocked rats restored normal serum FSH (11·1 2·5 ng/ml) and LH (12·7 2·9 ng/ml) levels.
Effect of AP treatment on pituitary responsiveness to LHRH on the pro-oestrous afternoon in intact and OVX rats
LHRH injection restored normal FSH and LH serum levels on the pro-oestrous afternoon in PB-blocked intact or OVX rats. The stimulating effect of LHRH on FSH and LH secretion was significantly blunted in both intact and OVX rats treated with RU486 or ZK299 (Fig. 2) .
Effect of APs on basal and LHRH-stimulated LH and FSH release in incubated pituitaries from rats in the pro-oestrous or metoestrous morning
The release of LH and FSH in the absence of LHRH did not differ significantly after the first or the second incubation period. Exposure of pituitaries to LHRH during the last 120 min increased LH and FSH release in a dose-dependent manner. The maximum LHRHstimulated LH release was about 10-fold for prooestrous (58 21 vs 565 104 ng/hemihypophysis) or metoestrous pituitaries (29 5 vs 272 38 ng/ hemihypophysis). LHRH-induced FSH secretion was only 3·5-fold, and no differences were observed between basal or LHRH-stimulated FSH from pro-oestrous (15 2 vs 45 4 ng/hemihypophysis) or metoestrous (14 1 vs 48 4 ng/hemihypophysis) pituitaries (Fig. 3) .
Both RU486 and ZK299 reduced basal and LHRHstimulated LH and FSH release from pro-oestrous pituitaries. Although differences were not statistically significant, RU486 appeared to be more efficient in terms of its suppressive effect than ZK299 (Fig. 3) . However, no effects were observed on basal and stimulated LH or FSH release in metoestrus pituitaries.
Discussion
The main findings of the present in vivo study were that the blockade of activation of PR with the APs RU486 and ZK299 reduced, at the time of spontaneous gonadotrophin surge, LH and FSH secretion in intact and OVX rats, and that RU486 and ZK299 reduced the ability of exogenous LHRH to restore FSH and LH surges in PB-blocked intact and OVX rats. These results suggest that: (i) the effects of the steroid antagonists on FSH and LH secretion were not due to antagonizing the action of pro-oestrous progesterone from ovarian origin; and (ii) both RU486 and ZK299 interfered with LHRH action at the pituitary level. Although adrenal hormones may be involved in gonadotrophin secretion in the pro-oestrous afternoon (Brann et al. 1991 , Putnam et al. 1991 and RU486 also blocks glucocorticoid actions (Moguilewsky & Philibert 1984 , Beck et al. 1993 , the findings of these experiments that ZK299, which has about 20-fold lower binding affinity to glucocorticoid receptor than does RU486 (Neef et al. 1984) , suppressed LH and FSH secretion Figure 2 LHRH ME content and pituitary responsiveness (serum LH and FSH concentrations) to LHRH (100 ng/0·5 ml saline, i.p.) at 1600 h on pro-oestrus in PB-blocked OVX or sham-OVX rats at 0900 h on pro-oestrus and injected (s.c.) with 4 mg RU486 (RU) or ZK299 (ZK) at the same time. Control injections were 0·2 ml oil. Values are means S.E.M. of 10-15 rats. **P<0·01 vs oil-injected rats; a=P<0·05 vs the corresponding value in non-PB-blocked rats (Fig. 1) ; ANOVA and Newman-Keuls multiple range test.
Figure 3
Effect of 20 nM RU486 (RU) and ZK299 (ZK) on LH and FSH release by pro-oestrous or metoestrous morning pituitaries incubated for 4 h in medium only or in medium with LHRH (1, 10 or 100 nM). Means S.E.M. of eight observations. Since no differences were found in LH or FSH release from metoestrous morning pituitaries incubated with medium alone, RU or ZK, they are shown together. a=P<0·01 vs metoestrous pituitaries; *P<0·05 and **P<0·01 vs pro-oestrous pituitaries incubated with medium only; ANOVA and Newman-Keuls multiple range test.
similarly (Figs 1 and 2) , suggest that, under the present experimental conditions, adrenal hormones are not involved. This interpretation was supported by the findings of the third experiment, in which, in the absence of cognate ligands (progesterone and glucocorticoids), APs significantly reduced basal and LHRH-stimulated secretion of FSH and LH by incubated pituitaries from pro-oestrous donors. However, APs had no effect on either basal or LHRH-stimulated FSH and LH release in incubated pituitaries from metoestrous donors or when injected on metoestrus in OVX rats (Sánchez-Criado et al. 1993 ). These observations indicated that the suppressive effect of APs on FSH and LH secretion, in vivo and in vitro, is dependent on the stage of the oestrous cycle.
The preovulatory increase of serum oestradiol concentration from metoestrus to pro-oestrus (Smith et al. 1975) is the primary stimulus for the increase in pituitary responsiveness to LHRH (Aiyer et al. 1976 ). This oestrogen dependency, together with the expression of a neural signal for LH release in the form of a surge of LHRH (Everett & Sawyer 1950) , brings about the preovulatory surge of LH (reviewed by Fink 1988). The in vitro results of the present study coincide fully with this concept; at pro-oestrus, the pituitary released more LH than at metoestrus. However, no differences in FSH release were observed between pro-oestrus and metoestrus. This finding suggested that a high oestrogen background on prooestrus is essential for the release of LH but not of FSH, reflecting the strong inhibitory ovarian influences on the secretory character of FSH (Muyan et al. 1994 , Farnworth 1995 throughout the oestrous cycle (Arai et al. 1996) . This contrasts with the negative (dioestrous phase) and positive (pro-oestrus) feedback effect of oestrogen (Arai et al. 1996) on LHRH-dependent LH secretion. Nevertheless, the importance of oestrogen-inducible PR in the pituitary (MacLusky & McEwen 1978) for determining the inhibitory action of RU486 and ZK299, is similar for both gonadotrophins. This is because APs reduced basal and LHRH-stimulated secretion of both FSH and LH in pro-oestrus but not in metoestrus.
These results, as well as those obtained previously (Ortmann et al. 1989 , Waring & Turgeon 1992 , Turgeon & Waring 1994 , suggest that when there is a high rate of LHRH-dependent gonadotrophin secretion, ligand-dependent and ligand-independent activation of oestrogen-inducible PR converge and facilitate FSH and LH secretion. Since activation of PR enhances the sensitivity of the pituitary to LHRH (McPherson & Mahesh 1979 , Sarkar & Fink 1979 and enhances the action of several pituitary responsiveness factors (Bauer-Dantoin et al. 1993 , Sahu et al. 1997 , Szabo et al. 1998 , the intrinsic mechanism of the inhibitory effects of APs on LHRH-dependent gonadotrophin secretion has yet to be determined.
With the exception of gonadotrophin secretion in pro-oestrus, which is strictly dependent on LHRH (Sarkar et al. 1976 , Blake & Kelch 1981 , the control of FSH and LH secretion diverges under a variety of physiological and experimental conditions. Transient LHRH-independent FSH release (Hasegawa et al. 1981) during the oestrous cycle of the rat occurs after unilateral OVX on metoestrus and during the early hours of oestrus (secondary surge of FSH), due to the release of stimulatory actions of activin-B within the anterior pituitary (DePaolo et al. 1992 ) brought about by the surgical or physiological decrease in ovarian inhibin secretion (Hasegawa et al. 1989) . Administration of APs blocks the LHRHindependent transient FSH surges after unilateral OVX on metoestrus (Sánchez-Criado et al. 1992a ) and at early oestrus (Knox & Schwartz 1992 , Sánchez-Criado et al. 1992b . Recent experiments have shown that this action of RU486 is the consequence of the blockade of ligandindependent activation of oestrogen-inducible PR (Knox et al. 1996 , Szabo et al. 1996 , probably interfering with activin-mediated signal transduction to stimulate FSH secretion in the absence of circulating inhibin (Szabo et al. 1998) .
Blockade of PR activation by administration of RU486 on metoestrus has no effect on either FSH or LH serum concentrations in OVX rats (Sánchez-Criado et al. 1993) . Furthermore, the results obtained here show that, in the absence of the natural ligand, APs did not interfere with basal and LHRH-stimulated FSH or LH secretion in incubated pituitaries from metoestrous donors. These findings show that during the low secretion rate of gonadotrophin (dioestrous phase), APs block only the ovarian progesterone inhibitory effect of activation of oestrogen-inducible PR during metoestrus (Ortmann et al. 1989) .
Bearing in mind results obtained previously, the present data support the hypothesis that stimulation of LH and/or FSH release (LHRH-dependent preovulatory surge of LH and FSH on the pro-oestrous afternoon and activinstimulated secondary surge of FSH during early oestrus), which account for ovulation and follicular recruitment respectively, is ensured by synergistic ligand-independent and ligand-dependent activation of PR at hypothalamic (Lee et al. 1990 , Sánchez-Criado et al. 1994 , Levine 1997 and/or pituitary levels (present results). In contrast, during the period of low secretion rate of gonadotrophins, inhibition of FSH (from late oestrus and throughout the dioestrous phase) and LH (from early oestrus up to dioestrous phase) secretion due to PR activation is associated with ovarian progesterone action.
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